Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease

Pepducins are membrane-tethered, cell-penetrating lipopeptides that target the cytoplasmic surface of their cognate receptor. Here, we report the first human use of a protease-activated receptor-1-based pepducin, which is intended as an antiplatelet agent to prevent ischemic complications of percuta...

Full description

Saved in:

Bibliographic Details
Published in:	Arteriosclerosis, thrombosis, and vascular biology Vol. 36; no. 1; p. 189
Main Authors:	Gurbel, Paul A, Bliden, Kevin P, Turner, Susan E, Tantry, Udaya S, Gesheff, Martin G, Barr, Travis P, Covic, Lidija, Kuliopulos, Athan
Format:	Journal Article
Language:	English
Published:	United States 01.01.2016
Subjects:	Adult Aged Blood Platelets - drug effects Blood Platelets - metabolism Cell-Penetrating Peptides - administration & dosage Cell-Penetrating Peptides - adverse effects Cell-Penetrating Peptides - pharmacokinetics Coronary Artery Disease - blood Coronary Artery Disease - diagnosis Coronary Artery Disease - therapy Dose-Response Relationship, Drug Female Half-Life Humans Infusions, Intravenous Lipopeptides - administration & dosage Lipopeptides - adverse effects Lipopeptides - pharmacokinetics Male Middle Aged Percutaneous Coronary Intervention - adverse effects Platelet Aggregation - drug effects Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - pharmacokinetics Platelet Function Tests Receptor, PAR-1 - antagonists & inhibitors Receptor, PAR-1 - metabolism Treatment Outcome coronary artery disease collagen aspirin risk factors lipopeptides
ISSN:	1524-4636, 1524-4636
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!